BioSpectra Revenue and Competitors

Bangor, PA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • BioSpectra's estimated annual revenue is currently $35.6M per year.(i)
  • BioSpectra's estimated revenue per employee is $201,000

Employee Data

  • BioSpectra has 177 Employees.(i)
  • BioSpectra grew their employee count by 9% last year.

BioSpectra's People

NameTitleEmail/Phone
1
EVP Quality SystemsReveal Email/Phone
2
VP FinanceReveal Email/Phone
3
VP Global Commercial ProgramReveal Email/Phone
4
VP Supply Chain OperationsReveal Email/Phone
5
Associate DirectorReveal Email/Phone
6
Director FinanceReveal Email/Phone
7
Senior Director, Information SystemsReveal Email/Phone
8
Director Materials ManagementReveal Email/Phone
9
Associate Director QualityReveal Email/Phone
10
Director Laboratory ServicesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$43.2M2156%N/AN/A
#2
$81.8M40710%N/AN/A
#3
$11.7M580%N/AN/A
#4
$1011.8M5034-9%N/AN/A
#5
$44.8M2231%N/AN/A
#6
$13.1M655%N/AN/A
#7
$16.5M8241%N/AN/A
#8
$17.3M86-5%N/AN/A
#9
$67.9M33823%N/AN/A
#10
$14.9M747%N/AN/A
Add Company

What Is BioSpectra?

BioSpectra is a FDA registered, cGMP compliant, contract manufacturer and commercial producer of biological buffers, pharmaceutical excipients and laboratory reagents. BioSpectra manufactures pH stabilizing biological buffers for the biopharmaceutical industry. These biological buffers offer low UV absorptivity, minimal reactivity, stable pH and high solubility in water for use in various biological applications. The excipients offered by BioSpectra’s Bulk BioPharm Manufacturing Division are produced in accordance with cGMP guidelines to provide the highest quality materials available to the biopharmaceutical industry. These excipients include Tromethamine, Tris Hydrochloride, Urea, Ammonium Sulfate, Guanidine Hydrochloride, MOPS, HEPES, MES and other related intermediates.

keywords:N/A

N/A

Total Funding

177

Number of Employees

$35.6M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BioSpectra News

2022-04-19 - HEPES Market Size, Outlook And Forecast | Avantor, Thermo ...

... Biological Industries, Cayman Chemical, SERVA Electrophoresis GmbH, Bio-Techne, BioSpectra, Corning, FUJIFILM Irvine Scientific, Dojindo Laboratories,...

2022-04-06 - Pa. primary election 2022: See how much money the GOP ...

In 2021, the biggest donors were Jodey Mutchler and Richard Mutchler, the president of pharmaceutical firm Biospectra, who gave $100,000.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$29.7M1802%N/A
#2
$67.1M186-7%N/A
#3
$51.4M1903%N/A
#4
$57.9M1950%N/A
#5
$70.3M1985%N/A